
ANIMAL SUBJECTS (IACUC)
Download our guidelines and procedures manual or search our document library.
The IACUC is a standing committee at Georgia State, whose composition and responsibilities are mandated by the Animal Welfare Act & Regulations (Public Law 98-198), the Public Health Service Policy and the Guide for the Care and Use of Laboratory Animals (8th Edition).
Georgia State’s Animal Welfare Assurance number in accordance with the Public Health Service (PHS) Policy for Humane Care and Use of Laboratory Animals is D16-00527 (A3914-01). This assurance number is current and applicable to all Georgia State research, research training, experimentation, biological testing and related activities.
2024 PHS Assurance to OLAW (contact IACUC for this information)
IACUC Members represent the following:
Gerontology, Arts & Sciences
Language Research Center, Arts & Sciences
Division of Animal Resources
Biology, Arts & Sciences
Neuroscience Institute, Arts & Sciences
Center for Molecular & Translational Medicine
Nursing/Physical Therapy
Non-Georgia State Affiliations
The committee meets the fourth Friday of each month at 11 am, except in November and December meetings will be held on the third Friday.
IACUC Membership and Appointment
- Chair
- Veterinarian
- Scientist
- Non-scientist
- Non-affiliated Member
The IACUC utilizes consultants when required. The consultant may offer opinions and advice, but may not discuss or vote on any application.
According to the 9th Code of Federal Regulations (CFR9), it is the responsibility of the chief executive officer (CEO) of the institution (in our case, the Georgia State President) to appoint all members of the IACUC, and the institutional official (IO). The CEO has delegated, in writing, the authority to appoint the IACUC members to the IO, the Vice President for Research and Economic Development.
IACUC Responsibilities
- a properly constituted and functioning Institutional Animal Care and Use Committee (IACUC);
- procedures for self-monitoring;
- an adequate veterinary care program;
- an occupational health and safety program;
- a personnel training program;
- an environment, housing and management program for animals; and
- appropriately maintained facilities for housing and support.
The IACUC represents society's concerns regarding the welfare of animal subjects used and is expected to be the conscience of the institute on animal welfare concerns.
The IACUC is responsible for keeping abreast of changes in animal use legislation and guidelines and recommending modifications to the institution's program to ensure that research and the animal use program fully comply with the letter and spirit of the law.
The IACUC is not a scientific review group, per se. All projects should have received appropriate, mission related and scientifically sound reviews (by the grant review process) prior to reaching the IACUC. However, humane treatment and scientific methodology are closely related and often inseparable concepts. Therefore, the committee may discuss and review science only as it relates specifically to animal use.
IACUC Review of Protocols and Amendments
All continuing protocols that involve covered species under the Animal Welfare Act must also receive an annual review to ensure that no significant deviations from established and approved procedures have occurred. All principal investigators who work with AWA covered species are required to complete an annual review report as part of this process.
When reviewing protocols, the IACUC ensures that:
- All procedures involving animals will avoid or minimize pain and distress to the animal(s).
- The principal investigator has considered alternatives to procedures that cause more than momentary pain or distress to the animals.
- The principal investigator has provided written assurance that the protocol proposed does not unnecessarily duplicate previous experiments.
- Appropriate anesthetics and analgesics are used when necessary.
- Personnel are properly trained to perform the proposed procedures.
- Activities that involve surgery provide for appropriate pre-operative and post-operative care and aseptic practices are followed.
- Methods of euthanasia are consistent with those set forth by the American Veterinary Medical Association's Panel on Euthanasia.
IACUC Program Review and Facilities Inspections
IACUC Investigations and Reports
Procedures & Timelines for IACUC Protocol Reviews
- The IACUC's current review process of new animal research protocol applications goal is to reduce the number of revision cycles and shorten the time to protocol approval. Meeting these objectives requires that investigators, as well as IACUC and Veterinary reviewers adhere to submission and revision deadlines as outlined below. Thank you for your cooperation.
- 1. Principal Investigators must submit new protocols to the iMedRIS electronic protocol management system for initial processing by noon on the last Monday of the month to be eligible for review at the next month’s IACUC meeting.
- 2. The protocol will undergo a pre-review screening by the IACUC staff and the protocol may be sent back for revision by the end of the same Monday it was submitted.
- 3. If the protocol is sent back after pre-review for any revisions, the PI has until noon Wednesday of the same week (48 hours hrs. after submission) to return the revised protocol.
- 4. After the screening (and revision if needed), the protocol will be reviewed by the veterinarian and the designated reviewers. Those reviewers have until noon on the following Wednesday (5 business days) to complete their review. If the protocol requires revision, it will be sent back to the PI on that Wednesday.
- 5. If the protocol is sent back to the PI for revisions after the initial review, the PI has until noon on the following Wednesday (5 business days) to re-submit the revised protocol.
IACUC Submission Deadline | Pre-review revisions deadline for PI | Vet and DMR consult deadline | Vet / DMR revisions deadline for PI | IACUC Meeting Date |
---|---|---|---|---|
Noon, January 2, 2025 | Noon, January 3, 3025 | Noon, January 8, 2025 | Noon, January 15, 2025 | January 24, 2025 |
Noon, January 27, 2025 | Noon, January 29, 2025 | Noon, February 5, 2025 | Noon, February 12, 2025 | February 28, 2025 |
Noon, March 3, 2025 | Noon, March 5, 2025 | Noon, March 12, 2025 | Noon, March 19, 2025 | March 28, 2025 |
Noon, March 31, 2025 | Noon, April 2, 2025 | Noon, April 9, 2025 | Noon, April 16, 2025 | April 25, 2025 |
Noon, April 28, 2025 | Noon, April 30, 2025 | Noon, May 7, 2025 | Noon, May 14, 2025 | May 23, 2025 |
Noon, May 26, 2024 | Noon, May 28, 2024 | Noon, June 4, 2024 | Noon, June 11, 2024 | June 27, 2024 |
Noon, June 30, 2025 | Noon, July 2, 2025 | Noon, July 9, 2025 | Noon, July 16, 2025 | July 25, 2025 |
Noon, July 28, 2025 | Noon, July 30, 2025 | Noon, August 6, 2025 | Noon, August 13, 2025 | August 22, 2025 |
Noon, August 25, 2025 | Noon, August 27, 2025 | Noon, September 3, 2025 | Noon, September 10, 2025 | September 26, 2025 |
Noon, September 29, 2025 | Noon, October 1, 2025 | Noon, October 8, 2025 | Noon, October 15, 2025 | October 24, 2025 |
Noon, October 27, 2025 | Noon, October 29, 2025 | Noon, November 5, 2025 | Noon, November 12, 2025 | November 21, 2025 |
Noon, December 1, 2025 | Noon, December 3, 2025 | Noon, December 10, 2025 | Noon, December 17, 2025 | December 19, 2025 |
Noon, January 5, 2026 | Noon, January 7, 2026 | Noon, January 14, 2026 | Noon, January 21, 2026 | January 23, 2026 |
Noon, January 26, 2026 | Noon, January 28, 2026 | Noon, February 4, 2026 | Noon, February 11, 2026 | February 27, 2026 |
Anyone who will be listed as a PI on an IACUC protocol must review the IACUC PI responsibilities to make sure they are eligible and can fulfill those responsibilities.
All new protocol applications and amendments must be submitted via the iRIS electronic protocol management system according to the submission guidelines and by the deadlines on the IACUC calendar to be considered at the monthly IACUC meeting.
Log into iRIS with your Campus ID and Campus Password. This action loads your credentials into the iRIS database. To be added to an IACUC protocol you must be in the iRIS database.
If you have further questions, please contact the IACUC Office or refer to our IACUC Frequently Asked Questions.
Who needs to submit an IACUC application?
IMPORTANT: BEFORE animals can be ordered or used, you must complete an Animal Use Protocol Application and receive approval from IACUC.
New IACUC protocols
Amending and/or Renewing an Existing Protocol
Register for and use iRIS
Facility Access
Controlled Substances
No, any unused controlled substances must be transferred to a Reverse Distributer, a registrant authorized to receive them. You can contact the nearest DEA Field Office for a list of authorized Reverse Distributors and determine the appropriate method to transfer the substance. Transfer requires specific paperwork, such as Form 222. See the following link to find authorized Reverse Distributors in your area.
The Reverse Distributor website.
No! Unless a researcher is also licensed as a pharmacist, he/she cannot sell, distribute, or dispense controlled substances.
Some suppliers are licensed to take back unused portions of the substances, however, some are not. You will have to ask your supplier if they can accept the substance. This transfer requires specific paperwork, such as Form 222.
Only to a Reverse Distributor, a registrant authorized to receive them. You can contact the nearest DEA Field Office for a list of authorized Reverse Distributors and determine the appropriate method to transfer the substance. Transfer requires specific paperwork, such as Form 222. See the following link to find authorized Reverse Distributors in your area.
The Reverse Distributor website
Logs should document each use of the controlled substance. The information required includes:
- The date of removal/use
- The person administering the substance
- The volume removed from the bottle
- The use (e.g., animal/s to whom it is administered; secondary aliquot)
For administration to animals:
- Record the species and an animal identification that is as specific as possible.
- An individual ID for each individual animal that has an individual ID
- A cage or group ID and total number of animals, if no individual ID exists
- At minimum, the total number of animals if no cage or group ID exists
When creating a secondary dilution/cocktail:
- Record the identification number for the secondary dilution/cocktail bottle
Templates for log books and inventory sheets:
Form 1: Controlled Substances Authorized User Signature Log
Form 2: Controlled Substances Access Log
Form 3: Controlled Substances Security Checklist
Form 4: Controlled Substances Order Receipt Log for Controlled Substances Schedules I and II
Form 5: Controlled Substances Order Receipt Log for Controlled Substances Schedules III-V
Form 6: Controlled Substances Inventory
Form 7: Controlled Substances Current Use and Disposition Log
If a volume is removed from a primary bottle to create a dilution/cocktail in a secondary bottle, this use must be recorded in both bottles’ logs.
Document in the log for the primary bottle:
- the volume removed to make the secondary dilution/cocktail
- the identification number for the secondary dilution/cocktail bottle
Document in the log for the secondary dilution/cocktail bottle:
- the identification number for the originating primary bottle from which the substance was removed
- the volume from the primary bottle used to make the secondary dilution/cocktail
Templates for log books and inventory sheets:
Form 1: Controlled Substances Authorized User Signature Log
Form 2: Controlled Substances Access Log
Form 3: Controlled Substances Security Checklist
Form 4: Controlled Substances Order Receipt Log for Controlled Substances Schedules I and II
Form 5: Controlled Substances Order Receipt Log for Controlled Substances Schedules III-V
Form 6: Controlled Substances Inventory
Form 7: Controlled Substances Current Use and Disposition Log
Records must include tracking of each individual bottle/vial of controlled substance. The best practice is to assign a unique identification to each bottle. One method to identify the primary bottle:
- The first 2 letters of the drug name (e.g., KE for ketamine)
- The date of receipt (e.g., dd/mm/yy)
- The number assigned to this specific bottle if more than 1 bottle of the drug is received on the same day
Example: If you receive 2 bottles of ketamine on January 7, 2015:
Bottle 1: KE010715-1; Bottle 2: KE010715-2
Secondary bottles (dilutions/cocktails from a primary bottle) must also have a unique identification.
- Identify the secondary dilution/cocktail bottle based on the primary bottle identification, for example, by adding a letter after the bottle number.
Example: A secondary dilution bottle from the above bottle 1 could be: KE011515-1A
A separate log, in which all volumes removed are documented, must be maintained for each primary and secondary controlled substance bottle.
Templates for log books and inventory sheets:
Form 1: Controlled Substances Authorized User Signature Log
Form 2: Controlled Substances Access Log
Form 3: Controlled Substances Security Checklist
Form 4: Controlled Substances Order Receipt Log for Controlled Substances Schedules I and II
Form 5: Controlled Substances Order Receipt Log for Controlled Substances Schedules III-V
Form 6: Controlled Substances Inventory
Form 7: Controlled Substances Current Use and Disposition Log
Registrants must inventory all controlled substances on hand at least every 2 years. An inventory record must contain:
- The date the inventory is completed
- Whether the inventory is completed at the beginning or end of the business day
- The names of each controlled substance
- The form of the substance (e.g., 10 mg tablet, 100mg/ml)
- The number of containers of each form and the number of dosage units in each container (e.g., 28 pills, 7.5 mls)
Templates for log books and inventory sheets:
Form 1: Controlled Substances Authorized User Signature Log
Form 2: Controlled Substances Access Log
Form 3: Controlled Substances Security Checklist
Form 4: Controlled Substances Order Receipt Log for Controlled Substances Schedules I and II
Form 5: Controlled Substances Order Receipt Log for Controlled Substances Schedules III-V
Form 6: Controlled Substances Inventory
Form 7: Controlled Substances Current Use and Disposition Log
Controlled substances that are expired or will not be used may disposed of by one of these 3 methods:
- Returning the substance to the supplier:
Some suppliers are licensed to take back unused portions of the substances, however, some are not. You will have to ask your supplier if they can accept the substance. This transfer requires specific paperwork, such as Form 222.
- Transferring the substances to a “Reverse Distributor”, a registrant authorized to receive and destroy such materials:
Substances may only be transferred to a Reverse Distributor, a registrant authorized to receive them. You can contact the nearest DEA Field Office for a list of authorized Reverse Distributors and determine the appropriate method to transfer the substance. Transfer requires specific paperwork, such as Form 222. See the following link to find authorized Reverse Distributors in your area.
The Reverse Distributor website
- Destroying the substance on site
Substances can only be destroyed on site with pre-approval from the DEA. Permission to destroy a controlled substance must be obtained from the local DEA Field Office in order to destroy the substance on site.
Specific methods must be used, that render the substance “non-retrievable”. Note that methods such as flushing, rinsing down the drain, mixing with materials such as coffee grounds or cat litter are not acceptable. Commercially available active-charcoal chemical digestion can be used to appropriately render the substance “non-retrievable”.
For an alphabetical listing of controlled substances, go to the DEA Diversion website.
Researchers who wish to use controlled substances in their research must register with both the State Board of Pharmacy and the federal DEA.
*Note: Researchers with other professional licenses (veterinarian, pharmacist, medical doctor) may have different license options/requirements.
At Georgia State University, researchers are currently required to obtain their own DEA license. Note that anyone using the substances must be listed on the license as an authorized user.
STEP 1. State of Georgia
First, a researcher must obtain a Georgia Board of Pharmacy Researcher Permit. The application is available at the Board of Pharmacy website. The form for researcher applications is the “Pharmacy Facility Application.” On the form, under “License Type” choose “Researcher Pharmacy” and complete the appropriate sections of the form. According to the form, you should allow a minimum of 25 business days for processing of the application.
STEP 2. Federal
Once the Georgia Board of Pharmacy issues a permit, a researcher must obtain a federal DEA license. Form 225 is the appropriate federal application form for research use of controlled substances. According to the DEA Diversion Office, the average processing time for a new DEA registration is 4-6 weeks.
The Office of Diversion Control website includes links for online registration and renewal forms, as well as a pdf of Form 225. Note researchers registering for Schedule I approval cannot submit their initial application online.
Information and assistance for federal application can be found at:
- The Office of Diversion Control website
- From a DEA field office (see Informational Resources below for contact information)
- By contacting the Registration Call Center at 1-800-882-9539.
If any controlled substances are lost or stolen, the registrant must notify the nearest DEA Field Office and complete DEA Form 106.
The use of controlled substances is regulated by federal and state laws and regulations. The US Department of Justice Drug Enforcement Agency (DEA) is the lead federal law enforcement agency responsible for enforcing these laws and regulations. In Georgia, the State Board of Pharmacy provides the oversight.
Both federal and state guidelines govern the responsible use of controlled substances in research, and the use of controlled substances by researchers requires registration and licensing at the federal and state levels.
On the federal level, researchers are considered “practitioners,” which includes “physicians, dentists, veterinarians, researchers, hospitals, pharmacies, or other persons registered to do research, to dispense, or to use in teaching or chemical analysis a controlled substance in the course of professional practice.” In Georgia, the State Board of Pharmacy defines a “drug researcher” as “…a person, firm, corporation, agency, department, or other entity which handles, possesses, or utilizes controlled substances or dangerous drugs, as defined in Chapter 13 of Title 16, for purposes of conducting research, drug analysis, animal training, or drug education, as such purposes may be further defined by the board, and is not otherwise registered as a pharmacist, pharmacy, drug wholesaler, distributor, supplier, or medical practitioner.”
Controlled substances are categorized into one of five schedules based on the substance’s medical use, potential for abuse, and safety or dependence liability.
Schedule I (CI) Substance
The controlled substances in this schedule are those that have no accepted medical use in the United States (U.S.), are not accepted as safe for use under medical supervision, and have a high abuse potential.
Examples: heroin, marijuana, LSD, peyote
Schedule II (CII) Substances
The controlled substances in this schedule have a high abuse potential with severe psychological or physical dependence liability, but have accepted medical use in the U.S. CII controlled substances consist of certain narcotic, stimulant, and depressant drugs.
Examples: fentanyl, pentobarbital
Controlled substances are categorized into one of five schedules based on the substance’s medical use, potential for abuse, and safety or dependence liability.
Schedule I (CI) Substance
The controlled substances in this schedule are those that have no accepted medical use in the United States (U.S.), are not accepted as safe for use under medical supervision, and have a high abuse potential.
Examples: heroin, marijuana, LSD, peyote
Schedule II (CII) Substances
The controlled substances in this schedule have a high abuse potential with severe psychological or physical dependence liability, but have accepted medical use in the U.S. CII controlled substances consist of certain narcotic, stimulant, and depressant drugs.
Examples: fentanyl, pentobarbital
The regulations specify the minimum security standards for controlled substances. Controlled substances must be stored in a securely locked cabinet of “substantial construction” (i.e., metal). The cabinet should not be easily broken into or removed. For example, a metal drug “lock box” bolted to the wall or other fixed surface.
The US DOJ DEA Office of Diversion Control “Controlled Substances Security Manual: Security Requirements for Practitioners” has more information.
Registrants must maintain specific records. See your registration documents for more details.
Record keeping, in general, requires:
- Records must show the flow of controlled substances, from acquisition, to administration, to disposal. Time points to include are: acquisition, dispensing/administration, distribution, loss/stolen, disposal, and inventory.
- There must be 2 physically separate files—one file for schedule I and II substance records and one file for schedule III – V substance records. These files can be stored in the same location.
- Copies of order forms (DEA Form 222) must be stored in a securely locked cabinet.
- Records must be maintained for at least 2 years.
- Records must be readily retrievable.
Other Resources
Policies and Forms
Controlled Substances DEA Power of Attorney Form
Form 1: Controlled Substances Authorized User Signature Log
Form 2: Controlled Substances Access Log
Form 3: Controlled Substances Security Checklist
Form 4: Controlled Substances Employee and Agent Screening Statement
Form 5: Controlled Substances Discrepancy Report
Form 6: Controlled Substances Order Receipt Log for Controlled Substances Schedules I and II
Form 7: Controlled Substances Order Receipt Log for Controlled Substances Schedules III-V
Form 8: Controlled Substances Inventory
Form 9: Controlled Substances Current Use and Disposition Log
Informational Resources
Georgia DEA Field Office
Contact a Registration Program Specialist at the Atlanta Division Office:
75 Spring Street SW
Suite 800
Atlanta, GA 30303
888-219-8689/866-533-6983
When GSU is Prime Awardee and All Animal Research Occurs at an External Institution
The Principal Investigator will access iRIS with their Campus ID and password. Create a Collaborative Form and provide the necessary information.
Georgia State requires a copy of the approved protocol and a copy of the IACUC approval letter from the collaborating institution.
Upon receiving the submission, the collaboration will receive a Georgia State protocol number, for tracking purposes. The Georgia State collaborative protocol will have an expiration date that matches the expiration date indicated on the Collaborating Institution’s IACUC Approval Letter.
NOTE: If the collaborative protocol and Approval Letter are not in English, the letter and protocol will need to be translated to English. Both the foreign language approvals and the English approvals must be included.
Please email IACUC or call 404-413-3508 if there are questions.
When Animal Research Occurs at GSU and at an External Institution
The Principal Investigator should contact the IACUC Office to indicate their plan to collaborate with an external colleague.
The PI will create a new study or submit an amendment to the current protocol that will involve a collaboration. The study/amendment must outline the procedures that will occur at GSU. A copy of the external collaborating PI’s approved IACUC protocol and IACUC approval letter must be uploaded to the GSU study/amendment submission. If a collaborating institution does not have a PHS Assurance, IACUC staff will provide guidance on securing an Interinstitutional Assurance (IIA).
Consider if an Institutional Biosafety Committee submission/amendment is necessary. IACUC approval is dependent upon any necessary approvals from ancillary review committees.
The PI must inform GSU’s Division of Animal Resources of their intent to receive animals from an outside institution, in advance. PIs are advised to contact GSU DAR early in the process. The animal care departments of both institutions must collaborate to determine the clinical status of the expected animals, modes of transportation, estimated timing of animal arrival to GSU and ownership of animals. GSU DAR is the point of contact for questions about the clinical assessment of animals and/or transportation arrangements to GSU animal facilities.
Once an IACUC study/amendment has been approved (along with IBC approval), IACUC staff will submit an MOU to the collaborating PI’s institution. Once both institutions’ IACUC representatives sign the document, the collaboration can begin. If an IIA is also required, GSU’s Institutional Official (not the PI), signs the document. The IACUC staff will send the signed IIA to the Office of Laboratory Welfare (OLAW) for approval of the collaboration. Once the IIA is approved by OLAW, the collaboration can begin.
When External Collaborators Conduct Animal Research at GSU
Fee-for-Service Advanced Translational Imaging Facility (ATIF)
Visit the ATIF website for more information and the ATIF Policies and Procedures page for additional requirements.
Additional Resources
FREQUENTLY ASKED QUESTIONS
IACUC
The Georgia State University IACUC utilizes the iMedRIS electronic protocol management system for protocol submissions (aka iRIS). Access https://gsu-iacuc.imedris.net and log in with your Campus ID and password. Everyone who will be listed on the protocol must first log onto the system. Once each person logs onto the system, their name and department will be added to the database which will then allow you to download them to your protocol.
Protocols must be submitted to iRIS on or before the last Monday of the month to be considered for review at that month’s IACUC meeting. If a submission deadline be missed, the review of the protocol will occur at the next month’s IACUC meeting. Please refer to the IACUC meeting calendar at https://ursa.research.gsu.edu/iacuc/iacuc-calendar/.
IACUC meetings are held on the fourth Friday of the month; except for November and December, when they are held on the third Friday due to Georgia State established holiday time off. A protocol requiring IBC (Institutional Biosafety Committee) or Radiation Protection Committee (RPC) approval should be submitted to the IBC and/or the RPC at the same time or before the IACUC submission. NOTE: The IACUC protocol will not be approved until approvals from ALL other committees have been received.
Please email [email protected] or call 404-413-3508 if there are questions.
Access https://gsu-iacuc.imedris.net and log in with your Campus ID and password. In order to revise the protocol, a new version of the form is required. Select the option to create new version. All requested stipulations must be answered within the new protocol version.
If a principal investigator disagrees with or feels the stipulation is not applicable, a response must be provided as to why the stipulation was rejected or was not applicable on the Review response form. The Principal Investigator may also request a meeting with the IACUC to discuss the differences of opinion. If no satisfactory resolution is reached, the principal investigator may submit a written appeal to the Institutional Official requesting assistance. The Institutional Official will attempt to mediate a solution acceptable to all. However, neither the Institutional Official nor any other administrative official can override a decision by the IACUC.
Please email [email protected] or call 404-413-3508 if there are questions.
Any changes in ongoing active protocols must be submitted to the IACUC using the Protocol Amendment Form in iRIS. Select the study to be amended, and select the protocol item Amendment to an Approved Protocol. Significant changes include changes that have, or have the potential to have, a negative impact on animal welfare. In addition, some changes or activities that may not have a direct impact on animal welfare are also considered to be significant. Please refer to the IACUC Manual (page 25) for examples of changes considered significant. The IACUC Office, in coordination with the IACUC Chair and/or Attending Veterinarian, will make a determination if the changes are considered significant or minor using criteria set by the NIH Office of Laboratory Animal Welfare.
All amendments expire no later than the three-year anniversary of the initial IACUC approval of the parent protocol. As with new protocol submissions, consultation with the Attending Veterinarian must occur on all protocol amendments prior to review by the IACUC.
Please email [email protected] or call 404-413-3508 if there are questions.
Access https://gsu-iacuc.imedris.net with your Campus ID and password. Access/click on the protocol. Click on the Personnel Amendment Form for Animal Protocols. This same form must be used to remove any personnel no longer working on the protocol.
Personnel, other than the Principal Investigator, are added to a protocol via administrative action. The person added must complete the required AALAS Learning Library training, enroll in the Medical Monitoring Program for Vertebrate Animal Exposure, and attend a facility orientation session (if they have not done so previously) with the Department of Animal Resources. Information about the required AALAS Learning Library training and the Medical Monitoring Program for Vertebrate Animal Exposure can be found in the IACUC Manual.
Please email [email protected] or call 404-413-3508 if there are questions.
Access https://gsu-iacuc.imedris.net with your Campus ID and password. Access/click your protocol. Click on the Request for Continuation of an Animal Protocol. The Protocol Continuation Form must be submitted to the IACUC at least 30 days before the anniversary date of the approval.
Please email [email protected] or call 404-413-3508 if there are questions.
IACUC Protocols expire at the end of the three-year period, per federal law. To continue the work, a new protocol must be submitted to the IACUC. There is no provision for the IACUC to grant administrative extensions of that 3-year time interval. The Three Year Renewal is a de novo protocol application, and thus, reviewed as a new protocol application. The "copy" feature is available to help transfer protocol information to a new form for the renewal.
Please email [email protected] or call 404-413-3508 if there are questions.
Complete the enrollment form online in the Research Portal at https://mmpvae.gsu.edu/. Re-enrollment in the Medical Monitoring Program must be completed annually and is the responsibility of the investigator.
Please email [email protected] or call 404-413-3508 if there are questions.
Training courses are completed through the AALAS Learning Library website. Required training, by species, can be found in the Required Training document in the Compliance & Safety section under Working With Animal Subjects. Georgia State University encourages animal users to take full advantage of the breadth of courses offered beyond the required training. The training courses required are dependent on the procedures being conducted.
Please email [email protected] or call 404-413-3508 if there are questions.
The Georgia State IACUC Protocol Submission form has a section devoted to breeding. Questions will be asked to justify why you’ve chosen to breed animals, rather than purchase them from an approved vendor. Cost is not an acceptable justification for breeding versus purchase. You will also be asked to describe the mating system, how the animals you breed will be used, what happens to animals that are not used (e.g. do not have the correct sex or genotype) and to justify the number of breeders needed. A separate breeding protocol may be appropriate if you have several protocols that require breeding.
Please email [email protected] or call 404-413-3508 if there are questions.
To download the approval letter, please open the protocol using “Click to Open”, select “Submissions History” on the right-hand side of the page. Select “Completed Submissions” on the top- middle tab. Look under the column “View Outcome Letters” to open the letter and download to print.
Please email [email protected] or call 404-413-3508 if there are questions.
The IACUC Office, University Veterinarian, and the IACUC Chair are all able to assist you. In the event of an unannounced visit, send the inspector to the Office of Research Integrity, 58 Edgewood Avenue NE, 3rd Floor. For scheduled visits please contact the Office of Research Integrity by email at [email protected] or call 404-413-3508.
Please email [email protected] or call 404-413-3508 if there are questions
The approval letters for the study are available in iRIS under the Miscellaneous tab and Letter Generation & Tracking.
Please email [email protected] or call 404-413-3508 if there are questions.
Animal research is a privilege and a trust. We are all stewards of their care. If you should have any concern about animal care and use at Georgia State University, tell someone in authority. Silence is complicity. If possible, discuss the situation with your supervisor. Animal care and use concerns can be reported to any IACUC Member, the University Veterinarian, DAR Management Staff, the Animal Health Technicians, the IACUC Office and/or the Office of Research Integrity. Concerns may also be reported anonymously on the IACUC website (see Report Compliance Issues on the lower half of the IACUC webpage).
Complications/adverse events should be reported to the IACUC at [email protected] as soon as possible.
If the event involves the welfare of an animal, contact the University's Attending Veterinarian at [email protected], 404-413-3636, or Assistant Director of Clinical Services at [email protected], 404-413-3553
The schedule for IACUC meetings, which are held on the fourth Friday of each month, except for November and December when the meeting is held on the third Friday of the month, can be found on the IACUC webpages. Notify the IACUC Office beforehand if you plan to attend the meeting so the agenda can be arranged to accommodate you.
IACUC meetings are open, but Investigators are required to leave the room while the IACUC discusses, deliberates, and votes on any protocol.
Any transfer of biological materials from Georgia State University to another research entity (university, non-profit, or commercial) must be governed by a Material Transfer Agreement. To initiate the process of obtaining a Material Transfer Agreement for outgoing materials, please complete the Outgoing Materials Form (found on the Legal Affairs website under “Intellectual Property”). Complete the Agreement and return it to Legal Affairs for review. All Material Transfer Agreements must be signed by the Vice President of Research and Economic Development (if the University is a party) or the Chair of the Georgia State University Research Foundation, Inc. before any transfers may take place.
EXTERNAL RESOURCES
Find Training
Find Resources
Report Compliance Issues
General Inquiries
[email protected]
Tiesha Murray, CPIA
Associate Director, Institutional Animal Use and Care Committee
404-413-3508
[email protected]
Alison Alesi, JD, CIP
Assistant Vice President, Regulatory Affairs
404-413-3514
[email protected]
Samantha Spencer
IACUC/IBC Compliance Officer
404-413-3515
[email protected]